Medicare Pricing Delay is Political Win for Amgen, Drug Maker »

Share on Facebook

Share on Twitter

A provision buried in the fiscal bill passed earlier this month gives Amgen, the world’s largest biotechnology firm, more time to sell a lucrative kidney dialysis drug without price restraints. Source Main page (current trends)

More about: Amgen, biotechnology firm, Drug Maker, Medicare Pricing Delay

Share on Facebook

Share on Twitter

Your comments